Antibiotice S.A. (BVB:ATB)
2.400
-0.030 (-1.23%)
At close: Mar 3, 2025
Antibiotice Balance Sheet
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 2.68 | 1.81 | 1.73 | 2.11 | 6.33 | Upgrade
|
Cash & Short-Term Investments | 2.68 | 1.81 | 1.73 | 2.11 | 6.33 | Upgrade
|
Cash Growth | 48.31% | 4.66% | -18.18% | -66.64% | 237.14% | Upgrade
|
Accounts Receivable | 298.03 | 221.13 | 196.51 | 269.76 | 252.9 | Upgrade
|
Other Receivables | - | 12.78 | 6.22 | 3.99 | 5.23 | Upgrade
|
Receivables | 298.03 | 233.91 | 202.73 | 273.75 | 258.13 | Upgrade
|
Inventory | 169.86 | 161.67 | 143.07 | 106.02 | 108.69 | Upgrade
|
Other Current Assets | 4.08 | 3.9 | 4.13 | 3.13 | 2.26 | Upgrade
|
Total Current Assets | 474.65 | 401.28 | 351.66 | 385.01 | 375.41 | Upgrade
|
Property, Plant & Equipment | 749.4 | 692.36 | 599.9 | 480.54 | 467.88 | Upgrade
|
Other Intangible Assets | 55.17 | 12.53 | 2.46 | 29.84 | 19.71 | Upgrade
|
Long-Term Deferred Charges | - | 33 | 30.29 | - | - | Upgrade
|
Other Long-Term Assets | - | - | - | - | -0 | Upgrade
|
Total Assets | 1,279 | 1,139 | 984.32 | 895.39 | 863 | Upgrade
|
Accounts Payable | 162.97 | 73.66 | 65.4 | 66.32 | 42.46 | Upgrade
|
Accrued Expenses | - | 9.69 | 2.87 | 8.4 | 7.66 | Upgrade
|
Short-Term Debt | 54.99 | 29.55 | 34.01 | 87.16 | 95.57 | Upgrade
|
Current Income Taxes Payable | - | - | - | 9.61 | 11.19 | Upgrade
|
Current Unearned Revenue | 0.31 | 0.73 | 0.6 | 3.47 | 2.05 | Upgrade
|
Other Current Liabilities | 10.31 | 76.84 | 33.81 | 24.17 | 27.77 | Upgrade
|
Total Current Liabilities | 228.58 | 190.47 | 136.69 | 199.14 | 186.7 | Upgrade
|
Long-Term Debt | 85.72 | 36.75 | 46.97 | 57.62 | 65.44 | Upgrade
|
Long-Term Unearned Revenue | 5.36 | 1.59 | 1.86 | 2.16 | 2.47 | Upgrade
|
Long-Term Deferred Tax Liabilities | 61.95 | 63.4 | 57.82 | 31.48 | 31.12 | Upgrade
|
Total Liabilities | 381.6 | 292.21 | 243.34 | 290.4 | 285.73 | Upgrade
|
Common Stock | 67.13 | 67.13 | 67.13 | 67.13 | 67.13 | Upgrade
|
Retained Earnings | 616.53 | 554.41 | 476.09 | -33.15 | -35.34 | Upgrade
|
Comprehensive Income & Other | 213.95 | 225.42 | 197.76 | 571.01 | 545.47 | Upgrade
|
Shareholders' Equity | 897.61 | 846.96 | 740.98 | 604.99 | 577.27 | Upgrade
|
Total Liabilities & Equity | 1,279 | 1,139 | 984.32 | 895.39 | 863 | Upgrade
|
Total Debt | 140.71 | 66.3 | 80.98 | 144.78 | 161.01 | Upgrade
|
Net Cash (Debt) | -138.03 | -64.49 | -79.25 | -142.67 | -154.68 | Upgrade
|
Net Cash Per Share | -0.21 | -0.10 | -0.12 | -0.21 | -0.23 | Upgrade
|
Filing Date Shares Outstanding | 671.34 | 671.34 | 671.34 | 671.34 | 671.34 | Upgrade
|
Total Common Shares Outstanding | 671.34 | 671.34 | 671.34 | 671.34 | 671.34 | Upgrade
|
Working Capital | 246.07 | 210.81 | 214.97 | 185.87 | 188.71 | Upgrade
|
Book Value Per Share | 1.34 | 1.26 | 1.10 | 0.90 | 0.86 | Upgrade
|
Tangible Book Value | 842.44 | 834.44 | 738.52 | 575.15 | 557.56 | Upgrade
|
Tangible Book Value Per Share | 1.25 | 1.24 | 1.10 | 0.86 | 0.83 | Upgrade
|
Land | - | 204.79 | 203.67 | 189.93 | 189.93 | Upgrade
|
Buildings | - | 312.77 | 267.97 | 157.46 | 135.88 | Upgrade
|
Machinery | - | 296.48 | 271.21 | 234.38 | 204.77 | Upgrade
|
Construction In Progress | - | 42.67 | 9.09 | 64.71 | 81.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.